| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 5 |
| 1 | ASPIRIN | 4 |
| 2 | ASPIRIN 325 MG | 4 |
| 3 | ASPIRIN 81 MG | 4 |
| 4 | METHOTREXATE | 4 |
| 5 | METHOTREXATE SODIUM | 4 |
| 6 | FOLIC ACID | 3 |
| 7 | PREDNISOLONE | 3 |
| 8 | PREDNISOLONE ORAL | 3 |
| 9 | PREDNISOLONE ORAL SOLUTION | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRETOMANID | 1 | 0.0013 |
| 1 | CABOTEGRAVIR SODIUM | 1 | 0.0006 |
| 2 | GALANTAMINE HYDROBROMIDE | 1 | 0.0006 |
| 3 | VUTRISIRAN | 1 | 0.0003 |
| 4 | ISATUXIMAB | 1 | 0.0002 |
| 5 | CLOFAZIMINE | 1 | 0.0002 |
| 6 | CABOTEGRAVIR AND RILPIVIRINE | 1 | 0.0002 |
| 7 | BOSUTINIB | 1 | 0.0001 |
| 8 | APALUTAMIDE | 1 | 0.0001 |
| 9 | TAFAMIDIS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 3 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 5 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 3 | 0.0000 |
| 6 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 2 | 0.0000 |